SYNOXA SCIENCES

Synoxa Sciences, Inc. is a Raleigh, NC based discovery-stage startup company working to develop novel small molecule antibiotics that are effective against multidrug-resistant bacterial infections... The goal of our company is to provide help to patients with life-threatening infections, particularly infections that are resistant to existing treatments and/or are complicated by biofilms. We are pursuing these goals based on two technologies developed in the lab of Dr. Joshua Pierce at NC State University... Natural products have historically been the predominant source of small molecule antibiotics. Although semi-synthetic modification of natural products has been a go-to method to generate new generations of existing antibiotics, we are committed to leveraging efficient and scalable chemical synthesis to prepare natural products from readily available building blocks to develop new classes of antibiotics. Based on our platform published in Angewandte Chemie in 2018, we are..

Also known as: Synoxa Sciences, Inc.